0001678007-16-000001.txt : 20160712 0001678007-16-000001.hdr.sgml : 20160712 20160711195246 ACCESSION NUMBER: 0001678007-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160712 DATE AS OF CHANGE: 20160711 EFFECTIVENESS DATE: 20160712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Travus Therapeutics, Inc. CENTRAL INDEX KEY: 0001678007 IRS NUMBER: 471965475 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-266753 FILM NUMBER: 161762998 BUSINESS ADDRESS: STREET 1: 101 N. CHESTNUT ST., SUITE 104 CITY: WINSTON-SALEM STATE: NC ZIP: 27101 BUSINESS PHONE: (760) 994-8020 MAIL ADDRESS: STREET 1: 101 N. CHESTNUT ST., SUITE 104 CITY: WINSTON-SALEM STATE: NC ZIP: 27101 D 1 primary_doc.xml X0707 D LIVE 0001678007 Travus Therapeutics, Inc. 101 N. Chestnut St., Suite 104 Winston-Salem NC NORTH CAROLINA 27101 (760) 994-8020 DELAWARE None None Corporation true 2014 John Finn 101 N. Chestnut St., Suite 104 Winston-Salem NC NORTH CAROLINA 27101 Executive Officer Director Jerel Davis 101 N. Chestnut St., Suite 104 Winston-Salem NC NORTH CAROLINA 27101 Director Biotechnology Decline to Disclose 06b false 2016-06-06 false true true true false 0 2250000 750000 1500000 Securities offered consist of promissory notes convertible into shares of convertible preferred stock, warrants exercisable for shares of convertible preferred stock and the common stock underlying the convertible preferred stock. false 4 0 0 0 false Travus Therapeutics, Inc. /s/ John Finn John Finn President 2016-07-08